共 50 条
- [41] Potent novel inhibitors against hepatitis C virus NS3 (HCV NS3 GT-3a) protease domainJOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2020, 101Ikram, SaimaAhmad, JamshaidRehman, Irshad-UrDurdagi, Serdar
- [42] Development of hepatitis C virus (HCV) chimeric replicons for identifying broad spectrum NS3 protease inhibitorsANTIVIRAL RESEARCH, 2007, 74 (03) : A38 - A38Binder, JosephTetangco, SelwynaWick, MeganMaegley, KarenLingardo, LauraPatick, AmySmith, George
- [43] Synthesis of Grazoprevir, a Potent NS3/4a Protease Inhibitor for the Treatment of Hepatitis C VirusORGANIC LETTERS, 2018, 20 (22) : 7261 - 7265Xu, FengKim, JungchulWaldman, JacobWang, TaoDevine, Paul
- [44] Discovery of a second generation, pan genotype NS3/4A protease inhibitor (BMS-986144) for the treatment of hepatitis CABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250Scola, PaulSun, Li-QiangGillis, EricBowsher, MichaelChen, JieWang, XiangdongSit, Sing-YuengChen, YanZheng, ZhizhenD'Andrea, StanleySin, NyVenables, BrianMull, EricChen, QianKandhasamy, SarkunamPulicharla, NagalakshmiVishwakrishnan, SureshbabuReddy, SubbaTrivedi, RaviSinha, SarmisthaSivaprasad, SankarRao, AbhijithDesai, SalilGhosh, KaushikRajamani, RamkumarFriborg, JacquesLevine, StevenChen, ChaoqunFalk, PaulJenkins, SusanKramer, MelissaHaskel, RoyJohnson, KimberlyLoy, JamesLevesque, PaulZhu, JiaCockett, MarkMeanwell, NicholasMcPhee, Fiona
- [45] Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (13) : 3453 - 3457Sheng, X. ChristopherPyun, Hyung-JungChaudhary, KleemWang, JianyingDoerffler, EdwardFleury, MelissaMcMurtrie, DarrenChen, XiaowuDelaney, William E.Kim, Choung U.
- [46] Discovery of Narlaprevir (SCH 900518): A Potent, Second Generation HCV NS3 Serine Protease InhibitorACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (02): : 64 - 69Arasappan, AshokBennett, FrankBogen, Stephane L.Venkatraman, SrikanthBlackman, MelissaChen, Kevin X.Hendrata, SiskaHuang, YuhuaHuelgas, Regina M.Nair, LathaPadilla, Angela I.Pan, WeidongPike, RussellPinto, PatrickRuan, SumeiSannigrahi, MousumiVelazquez, FranciscoVibulbhan, BanchaWu, WanliYang, WeiyingSaksena, Anil K.Girijavallabhan, ViyyoorShih, Neng-YangKong, JiansheMeng, TaoJin, YanWong, JesseMcNamara, PaulProngay, AndrewMadison, VincentPiwinski, John J.Cheng, Kuo-ChiMorrison, RichardMalcolm, BruceTong, XiaoRalston, RobertNjoroge, F. George
- [47] Molecular principles behind Boceprevir resistance due to mutations in hepatitis C NS3/4A proteaseGENE, 2015, 570 (01) : 115 - 121Nagpal, NehaGoyal, SukritiWahi, DivyaJain, RituJamal, SalmaSingh, AditiRana, PreetiGrover, Abhinav
- [48] Danoprevir, a small-molecule NS3/4A protease inhibitor for the potential oral treatment of HCV infectionCURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (08) : 951 - 963Deutsch, MelaniePapatheodoridis, George V.
- [49] An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virusNATURE, 2003, 426 (6963) : 186 - 189Lamarre, DAnderson, PCBailey, MBeaulieu, PBolger, GBonneau, PBös, MCameron, DRCartier, MCordingley, MGFaucher, AMGoudreau, NKawai, SHKukolj, GLagacé, LLaPlante, SRNarjes, HPoupart, MARancourt, JSentjens, RESt George, RSimoneau, BSteinmann, GThibeault, DTsantrizos, YSWeldon, SMYong, CLLlinàs-Brunet, M
- [50] An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virusNature, 2003, 426 : 186 - 189Daniel LamarrePaul C. AndersonMurray BaileyPierre BeaulieuGordon BolgerPierre BonneauMichael BösDale R. CameronMireille CartierMichael G. CordingleyAnne-Marie FaucherNathalie GoudreauStephen H. KawaiGeorge KukoljLisette LagacéSteven R. LaPlanteHans NarjesMarc-André PoupartJean RancourtRoel E. SentjensRoger St GeorgeBruno SimoneauGerhard SteinmannDiane ThibeaultYoula S. TsantrizosSteven M. WeldonChan-Loi YongMontse Llinàs-Brunet